Egyptian Journal of Radiology and Nuclear Medicine

Table 7 Final T and N stages of the cases in the neoadjuvant group detected by different imaging modalities

From: The additive role of dynamic contrast-enhanced and diffusion-weighted MR imaging in preoperative staging of breast cancer

Size (T)	SM	DCE-MRI	MRI-DWI	Pathology
T0	2/13 (15.3%)	7/13 (53.8%)	8/13 (61.5%)	7/13 (53.8%)
T1	5/13(38.4%)	1/13 (7.7%)	0/13	1/13 (7.7%)
T2	6/13 (46.1%)	5/13 (38.4%)	5/13 (38.4%)	4/13 (30.7%)
T3	0/13	0/13	0/13	0/13
T4	0/13	0/13	0/13	1/13 (7.7%)
Lymph node (N)	SM	DCE-MRI	MRI-DWI	Pathology
Nx	1/13 (7.7%)	1/13 (7.7%)	0/13	0/13
N0	8/13 (61.5%)	8/13 (61.5%)	9/13 (69.2%)	8/13 (61.5%)
N1	4/13 (30.7%)	4/13 (30.7%)	4/13 (30.7%)	2/13 (15.3%)
N2	0/13	0/13	0/13	5/13 (38.4%)

Back to article page